{"name":"Inmunova S.A.","slug":"inmunova-s-a","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Drug: INM004 Dose 1","genericName":"Drug: INM004 Dose 1","slug":"drug-inm004-dose-1","indication":"Other","status":"phase_1"},{"name":"Drug: INM004- Repeated dose","genericName":"Drug: INM004- Repeated dose","slug":"drug-inm004-repeated-dose","indication":"Other","status":"phase_1"},{"name":"INM004","genericName":"INM004","slug":"inm004","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"Drug: INM004 Dose 1","genericName":"Drug: INM004 Dose 1","slug":"drug-inm004-dose-1","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Drug: INM004- Repeated dose","genericName":"Drug: INM004- Repeated dose","slug":"drug-inm004-repeated-dose","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"INM004","genericName":"INM004","slug":"inm004","phase":"phase_3","mechanism":"INM004 is an immunotherapeutic agent designed to modulate immune responses, likely through activation or enhancement of anti-tumor immunity.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNTzlwTmlLWVJzSHh4MUQyZUMtYTA1REZ6dHFzamFiRTQtaTdiMW1sVzFDUUtjci1wSlhlcGVxVVZKTWd2Vi1oT05hR2NWWmtjQ2VBZldtRFRmSnVucDNnNmh0MTd0QUJQSHVhUFlmTE9fU0lTN1VMRDM0TzBvMzdIT01zSTMyeTd3T3oyVjBoOUZuWG9TWFUw?oc=5","date":"2026-03-24","type":"trial","source":"openPR.com","summary":"Diarrhea Clinical Trial Pipeline Expands as 25+ Companies Driving Innovation in the Therapeutics | DelveInsight - openPR.com","headline":"Diarrhea Clinical Trial Pipeline Expands as 25+ Companies Driving Innovation in the Therapeutics | DelveInsight","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_1":2,"phase_3":1},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}